Advancing Cardiovascular and Renal Health: The Collaboration between BioMe and Bacthera on BM109
BioMe, a prominent player in the field of Live Biotherapeutic Products (LBPs), has recently made significant strides with its latest drug development candidate, BM109, aimed at treating Cardiovascular Disease (CVD) and Chronic Kidney Disease (CKD) […]